The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection　― A Nationwide Cohort Study ―-Reference-Cited by-同舟云学术

The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection　― A Nationwide Cohort Study ―

Published:2018-05-25 Issue:6 Volume:82 Page:1623-1631
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Lin Ming-Shyan¹²,Chung Chang-Min²,Chang Ming-Ling³,Chen Mei-Yen⁴⁵,Chang Shih-Tai²,Chu Pao-Hsien⁶,Chen Tien-Hsing¹,Lin Wey-Yil⁷,Huang Tung-Jung⁸,Lin Yu-Sheng²

Affiliation:

1. Department of Cardiology, Chang Gung Memorial Hospital

2. Department of Cardiology, Heart Failure Center, Chang Gung Memorial Hospital

3. Liver Research Center and Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital

4. College of Nursing & Graduate Institute of Nursing, Chang Gung University of Science and Technology

5. Department of Nursing, Chang Gung University

6. Department of Cardiology, Heart Failure Center, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University

7. Department of Neurology, Landseed Hospital

8. Department of Pulmonary Disease and Critical Care, Chang Gung Memorial Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/6/82_CJ-17-1118/_pdf

Reference39 articles.

1. 1. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22: 7824–7840.

2. 2. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Extrahepatic manifestations of hepatitis C: A meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology 2016; 107: 1599–1608.

3. 3. Negro F, Forton D, Craxì A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 2015; 149: 1345–1360.

4. 4. Ambrosino P, Lupoli R, Di Minno A, Tarantino L, Spadarella G, Tarantino P, et al. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis. Int J Cardiol 2016; 221: 746–754.

5. 5. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000; 80: 1137–1142.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis;IJC Heart & Vasculature;2023-12

2. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals;Journal of Clinical Medicine;2022-09-29

3. Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients;Russian Journal of Cardiology;2022-03-12

4. Cardiovascular Implications of Immune Disorders in Women;Circulation Research;2022-02-18

5. Covid-19 and development of heart failure: mystery and truth;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-09-04